Zimmer Trabecular Metal Total Ankle PMCF
← catalyst calendarNCT02038140 · readout ≤ 406 d
Sponsored by Zimmer Biomet (industry) · ZBH — their whole pipeline →.
Phase
Not applicable
Status
Active, not recruiting
Study type
Interventional
Design
Na · None · Treatment
Enrollment
120estimated
Sites
11
Countries
Canada, Finland, Germany +3
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | Mar 2014 | not stated | When the study began enrolling |
| Primary completion | Sep 2027 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Dec 2027 | estimated | The whole study's end, after follow-up |
| First posted | 2014-01-16 | estimated | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-07-09 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Degenerative Arthritis
- Rheumatoid Arthritis
- Post Traumatic Arthritis
Intervention
- Device: Zimmer Trabecular Metal Total Ankle System — also filed as Primary Ankle Replacement, Total Ankle Arthroplasty, Total Ankle Replacement
Primary outcome
what the primary-completion date above is the date OFSurvivorship
measured 10 years
Permalink · ZBH's whole pipeline · Catalyst calendar · Every registered study · What changed